Comparison of oral loading dose of propafenone and amiodarone for converting recent-onset atrial fibrillation. PARSIFAL Study Group (Q73200648)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569658%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Comparison of oral loading dose of propafenone and amiodarone for converting recent-onset atrial fibrillation. PARSIFAL Study Group (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569658%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

1 reference

J J Blanc

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569658%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C Voinov

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569658%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M Maarek

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569658%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

1 November 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569658%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569658%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569658%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569658%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

1029-1032

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569658%20AND%20SRC:MED&resulttype=core&format=json

Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900493-2

The management of atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900493-2

Value of single oral loading dose of propafenone in converting recent-onset atrial fibrillation. Results of a randomized, double-blind, controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900493-2

A clinical study of amiodarone as a single oral dose in patients with recent-onset atrial tachyarrhythmia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900493-2

Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900493-2

Intravenous flecainide versus amiodarone for recent-onset atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900493-2

Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900493-2

Effects of amiodarone versus quinidine and verapamil in patients with chronic atrial fibrillation: results of a comparative study and a 2-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900493-2

Effectiveness of intravenous propafenone for conversion of atrial fibrillation and flutter of recent onset

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900493-2

A randomized comparison of external and internal cardioversion of chronic atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900493-2

A comparison of treatment of atrial fibrillation with low-energy intracardiac cardioversion and conventional external cardioversion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900493-2

Suppression of arrhythmias within hours after a single oral dose of amiodarone and relation to plasma and myocardial concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900493-2

Propafenone for conversion of recent-onset atrial fibrillation. A controlled comparison between oral loading dose and intravenous administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900493-2

The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900493-2

The efficacy and safety of intravenous propafenone versus intravenous amiodarone in the conversion of atrial fibrillation or flutter after cardiac surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900493-2

Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900493-2

A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900493-2

Clinical course of recent-onset atrial fibrillation treated with oral propafenone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900493-2

Intravenous propafenone in paroxysmal atrial fibrillation: a randomized, placebo-controlled, double-blind, multicenter clinical trial. Paroxysmal Atrial Fibrillation Italian Trial (PAFIT)-2 Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900493-2

Clinical efficacy of amiodarone as an antiarrhythmic agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900493-2

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900493-2

Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900493-2

Possible atrial proarrhythmic effects of class 1C antiarrhythmic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900493-2

Atrial flutter in patients treated for atrial fibrillation with propafenone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900493-2

Extreme tachycardia complicating the use of disopyramide in atrial flutter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900493-2

Regular ventricular rhythms in patients with symptomatic paroxysmal atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900493-2

10.1016/S0002-9149(99)00493-2

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569658%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference